Profile
Kari Grønås Dyvik formerly worked at Lytix Biopharma AS, as Director, Photocure ASA, as Manager-Pharmaceutical Development, Nycomed ASA, as Principal, GE Healthcare Ltd. (United Kingdom), as Principal, and Algeta ASA, as Senior Vice President-Operations from 2011 to 2013.
Ms. Dyvik received her graduate degree in 1989 from the University of Oslo.
Former positions of Kari Grønås Dyvik
| Companies | Position | End |
|---|---|---|
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Corporate Officer/Principal | - |
Nycomed ASA
Nycomed ASA Medical SpecialtiesHealth Technology Manufactures and sells pharmaceuticals and specialised products for life science research | Corporate Officer/Principal | - |
| PHOTOCURE ASA | Corporate Officer/Principal | - |
| LYTIX BIOPHARMA ASA | Director/Board Member | - |
| ALGETA ASA | Chief Operating Officer | - |
Training of Kari Grønås Dyvik
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Photocure ASA
Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
Nycomed ASA
Nycomed ASA Medical SpecialtiesHealth Technology Manufactures and sells pharmaceuticals and specialised products for life science research | Health Technology |
GE Healthcare Ltd. (United Kingdom)
GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Lytix Biopharma AS
Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
- Stock Market
- Insiders
- Kari Grønås Dyvik
















